The Paris Technology and Life Sciences team advised Tribun Health, a leading innovator in the field of digital pathology, on its Series B financing round, securing an investment of €15 million. This financing round is led by the Fonds Patient Autonome managed by Bpifrance, alongside several new investors, including Owkin and Vivalto Family, with whom the company has also signed commercial agreements, and the renewed support of its historic investor LBO France.
The Series B funding round's success represents an important accomplishment for Tribun Health, further strengthening the company's financial position and opening new opportunities for growth in Europe and North America.
Tribun Health powers the digital transformation of cancer diagnosis by designing innovative solutions. These solutions enable the management, analysis and sharing of cellular images for both diagnostic laboratories and pharmaceutical/biotech companies. The company offers customized support in digital pathology, focused on the customer’s expectations.
The Goodwin team was led by Thomas Dupont-Sentilles and Messan Dogbevi on corporate aspects and Marie Fillon on IP aspects.